Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03039426Phase 4Completed
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Ministry of Public Health. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03039426.